FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3137292381> ?p ?o ?g. }

• W3137292381 endingPage "1413" @default.
• W3137292381 startingPage "1403" @default.
• W3137292381 abstract "Abstract Background The incidence of traumatic brain injury (TBI) patients of older age with comorbidities, who are pre-injury treated with antithrombotic agents (antiplatelets and/or anticoagulants), has increased. In this study, our aim was to investigate if pre-injury antithrombotic treatment was associated with worse intracranial hemorrhagic/injury progression and clinical outcome in patients with severe TBI. Methods In this retrospective study, including 844 TBI patients treated at our neurointensive care at Uppsala University Hospital, Sweden, 2008–2018, 159 (19%) were pre-injury treated with antithrombotic agents. Demography, admission status, radiology, treatment, and outcome variables were evaluated. Significant intracranial hemorrhagic/injury evolution was defined as hemorrhagic progression seen on the second computed tomography (CT), emergency neurosurgery after the initial CT, or death following the initial CT. Results Patients with pre-injury antithrombotics were significantly older and with a higher Charlson comorbidity index. They were more often injured by falls and more frequently developed acute subdural hematomas. Sixty-eight (8%) patients were pre-injury treated with monotherapy of antiplatelets, 67 (8%) patients with anticoagulants, and 24 (3%) patients with a combination of antithrombotics. Pre-injury anticoagulants, but not antiplatelets, were independently associated with significant intracranial hemorrhagic/injury evolution in a multiple regression analysis. However, neither anticoagulants nor antiplatelets were associated with mortality and unfavorable outcome in multiple regression analyses. Conclusions Only anticoagulants were associated with intracranial hemorrhagic/injury progression, but no antithrombotic agent correlated with worse clinical outcome. Management, including early anticoagulant reversal, availability of emergency neurosurgery, and neurointensive care, may be important aspects for reducing the adverse effects of pre-injury antithrombotics." @default.
• W3137292381 created "2021-03-29" @default.
• W3137292381 creator A5020764620 @default.
• W3137292381 creator A5027492658 @default.
• W3137292381 creator A5082050889 @default.
• W3137292381 creator A5090892744 @default.
• W3137292381 date "2021-03-26" @default.
• W3137292381 modified "2023-10-18" @default.
• W3137292381 title "Pre-injury antithrombotic agents predict intracranial hemorrhagic progression, but not worse clinical outcome in severe traumatic brain injury" @default.
• W3137292381 cites W1948023428 @default.
• W3137292381 cites W1972491904 @default.
• W3137292381 cites W1977702253 @default.
• W3137292381 cites W1988544539 @default.
• W3137292381 cites W1997931646 @default.
• W3137292381 cites W2031636725 @default.
• W3137292381 cites W2034368138 @default.
• W3137292381 cites W2040636124 @default.
• W3137292381 cites W2054458452 @default.
• W3137292381 cites W2058673329 @default.
• W3137292381 cites W2061063479 @default.
• W3137292381 cites W2061975416 @default.
• W3137292381 cites W2067838998 @default.
• W3137292381 cites W2070921889 @default.
• W3137292381 cites W2076954584 @default.
• W3137292381 cites W2081834506 @default.
• W3137292381 cites W2136198531 @default.
• W3137292381 cites W2155070090 @default.
• W3137292381 cites W2165037395 @default.
• W3137292381 cites W2165766245 @default.
• W3137292381 cites W2168200470 @default.
• W3137292381 cites W2306092547 @default.
• W3137292381 cites W2472040764 @default.
• W3137292381 cites W2556603964 @default.
• W3137292381 cites W2610589330 @default.
• W3137292381 cites W2735433479 @default.
• W3137292381 cites W2762043977 @default.
• W3137292381 cites W2767770010 @default.
• W3137292381 cites W2773429178 @default.
• W3137292381 cites W2790916527 @default.
• W3137292381 cites W2890506140 @default.
• W3137292381 cites W2936988027 @default.
• W3137292381 cites W2957129721 @default.
• W3137292381 cites W2972355048 @default.
• W3137292381 cites W2997079181 @default.
• W3137292381 cites W3004606996 @default.
• W3137292381 cites W3015259488 @default.
• W3137292381 cites W3084265249 @default.
• W3137292381 cites W4211043869 @default.
• W3137292381 doi "https://doi.org/10.1007/s00701-021-04816-0" @default.
• W3137292381 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8053649" @default.
• W3137292381 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33770261" @default.
• W3137292381 hasPublicationYear "2021" @default.
• W3137292381 type Work @default.
• W3137292381 sameAs 3137292381 @default.
• W3137292381 citedByCount "8" @default.
• W3137292381 countsByYear W31372923812021 @default.
• W3137292381 countsByYear W31372923812022 @default.
• W3137292381 countsByYear W31372923812023 @default.
• W3137292381 crossrefType "journal-article" @default.
• W3137292381 hasAuthorship W3137292381A5020764620 @default.
• W3137292381 hasAuthorship W3137292381A5027492658 @default.
• W3137292381 hasAuthorship W3137292381A5082050889 @default.
• W3137292381 hasAuthorship W3137292381A5090892744 @default.
• W3137292381 hasBestOaLocation W31372923811 @default.
• W3137292381 hasConcept C118552586 @default.
• W3137292381 hasConcept C126322002 @default.
• W3137292381 hasConcept C12770488 @default.
• W3137292381 hasConcept C141071460 @default.
• W3137292381 hasConcept C165455791 @default.
• W3137292381 hasConcept C16568411 @default.
• W3137292381 hasConcept C17624336 @default.
• W3137292381 hasConcept C2777015399 @default.
• W3137292381 hasConcept C2777094939 @default.
• W3137292381 hasConcept C2777975874 @default.
• W3137292381 hasConcept C2778205648 @default.
• W3137292381 hasConcept C2781017439 @default.
• W3137292381 hasConcept C42219234 @default.
• W3137292381 hasConcept C71924100 @default.
• W3137292381 hasConceptScore W3137292381C118552586 @default.
• W3137292381 hasConceptScore W3137292381C126322002 @default.
• W3137292381 hasConceptScore W3137292381C12770488 @default.
• W3137292381 hasConceptScore W3137292381C141071460 @default.
• W3137292381 hasConceptScore W3137292381C165455791 @default.
• W3137292381 hasConceptScore W3137292381C16568411 @default.
• W3137292381 hasConceptScore W3137292381C17624336 @default.
• W3137292381 hasConceptScore W3137292381C2777015399 @default.
• W3137292381 hasConceptScore W3137292381C2777094939 @default.
• W3137292381 hasConceptScore W3137292381C2777975874 @default.
• W3137292381 hasConceptScore W3137292381C2778205648 @default.
• W3137292381 hasConceptScore W3137292381C2781017439 @default.
• W3137292381 hasConceptScore W3137292381C42219234 @default.
• W3137292381 hasConceptScore W3137292381C71924100 @default.
• W3137292381 hasIssue "5" @default.
• W3137292381 hasLocation W31372923811 @default.
• W3137292381 hasLocation W31372923812 @default.
• W3137292381 hasLocation W31372923813 @default.
• W3137292381 hasOpenAccess W3137292381 @default.
• W3137292381 hasPrimaryLocation W31372923811 @default.

• next